Finance

Lists
RADL3:BVMF
Raia Drogasil S/A
R$14.26
0.00%
(0.00) 1D
Nov 12, 6:04:00 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for RADL3...
Open
R$14.54
High
R$14.58
Low
R$14.12
Mkt. cap
24.99B
Avg. vol.
15.72M
Volume
7.10M
P/E ratio
18.39
52-wk high
R$27.01
52-wk low
R$13.50
EPS
R$0.78
Shares outstanding
1.75B
No. of employees
77K
Open
R$14.54
High
R$14.58
Low
R$14.12
Mkt. cap
24.99B
Avg. vol.
15.72M
Volume
7.10M
P/E ratio
18.39
52-wk high
R$27.01
52-wk low
R$13.50
EPS
R$0.78
Shares outstanding
1.75B
No. of employees
77K
News stories
From web sources and news partners
Profile
RD Saúde is the largest drugstore company in Latin America by revenue and market capitalization. With its headquarters in São Paulo, it has more than 3,000 pharmacies in Brazil with a national presence in all 27 states. The company's pharmacies are branded as Raia and Drogasil and are supplied by 14 distribution centers. The company also leads in online audience through its proprietary Raia and Drogasil mobile apps and websites, which accounted for 15.2% of 2023 retail gross revenues according to publicly filed financial statements. The company has 3.614 stores around Brazil. RD Saúde's top 3 competitors include Grupo DPSP, Pague Menos and Farmácias São João. Wikipedia
About Raia Drogasil S/A
CEORenato Cepollina Raduan
Employees77.4K
FoundedNov 10, 2011
Headquarters-
SectorConsumer Staples
IndustryDrug
Last report
Nov 4, 2026
Fiscal period
Q3 2026
R$0.25 / R$0.26
-3.19%miss
Revenue / Est. (BRL)
11.41B / 12.06B
-5.37%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
12.10B
10.57B
11.06B
11.41B
Cost of goods sold
8.54B
7.17B
7.36B
7.61B
Cost of revenue
8.54B
7.17B
7.36B
7.61B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.82B
2.75B
2.85B
2.96B
Operating expense
2.82B
2.94B
2.86B
2.98B
Total operating expenses
11.36B
10.11B
10.22B
10.59B
Operating income
747.67M
456.29M
838.88M
816.17M
Other non operating income
-62.76M
-28.28M
-48.97M
-31.70M
EBT including unusual items
303.18M
126.80M
530.34M
500.82M
EBT excluding unusual items
358.24M
129.38M
512.80M
500.93M
Income tax expense
12.64M
-20.47M
114.08M
92.56M
Effective tax rate
4.17%
-16.14%
21.51%
18.48%
Other operating expenses
-
192.84M
5.72M
16.41M
Net income
304.92M
158.96M
424.54M
408.25M
Net profit margin
2.52%
1.50%
3.84%
3.58%
Earnings per share
0.18
0.18
0.21
0.25
Interest and investment income
-
2.75M
3.44M
8.62M
Interest expense
-329.34M
-301.14M
-280.37M
-290.92M
Net interest expenses
-329.34M
-298.39M
-276.94M
-282.31M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.02B
662.92M
1.05B
1.04B
Gain or loss from assets sale
55.46M
639.00K
48.48M
13.43M
Upcoming events
AI content may include mistakes. Learn more
Google apps